Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

R Michael Dougherty


  • Director at Idera Pharmaceuticals Inc. (IDRA), 2019-10-03
  • Director at Trevena Inc (TRVN), 2019-05-16
  • Director at Marinus Pharmaceuticals Inc (MRNS), 2019-02-28
  • Director at Foundation Medicine Inc. (FMI), 2018-08-02
  • Director at Aviragen Therapeutics Inc. (AVIR), 2017-05-22
  • Director at Cempra Inc. (CEMP), 2017-01-06
  • Executive Chairman at Celator Pharmaceuticals Inc (CPXX), 2016-07-12
  • Director at Viropharma Inc (VPHM), 2014-01-29
  • President & Ceo at Adolor Corp (ADLR), 2011-12-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CEMP $18.45 2,000 Director 2,000 2015-10-26 Filing
TRVN $4.00 7,000 Director 7,000 2014-12-10 Filing
CPXX $2.15 20,000 Director 20,000 2014-11-18 Filing
VPHM $25.07 2,500 Director 7,000 2012-12-03 Filing
ADLR $1.18 30,000 Officer, Director 621,911 2010-12-23 Filing